Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurogene
Biotech
Neurogene stops Batten gene therapy after FDA denies request
Neurogene followed up a premarket setback to its Rett syndrome program Monday with a postmarket confirmation that development of another gene therapy has hit a wall.
Nick Paul Taylor
Nov 19, 2024 6:30am
FDA picks Denali, Neurogene and more for rare disease program
Jun 4, 2024 2:51pm
BioMarin CEO replaces commercial chief—Chutes & Ladders
Jan 19, 2024 8:30am
Neurogene inks Neoleukin reverse merger to fund gene therapies
Jul 18, 2023 8:47am
Neurogene adds another $115M to the pot
Dec 17, 2020 8:42am
